Deciding Factors: Answering the Questions of When, How, and Why When Individualizing Multiple Sclerosis Treatment

Deciding Factors: Answering the Questions of When, How, and Why When Individualizing Multiple Sclerosis Treatment

With an increasing range of disease-modifying treatment options for the ma…

Expiration Date: 6/14/2017

Max Credits: 0

View Activity

Expert Interviews on Treatment of Multiple Sclerosis: Shifting the Paradigm in 2015

Expert Interviews on Treatment of Multiple Sclerosis: Shifting the Paradigm in 2015

Treatment with disease modifying therapies (DMTs) can transform the otherw…

Expiration Date: 4/13/2016

Max Credits: 0

View Activity

Real life use of natalizumab and fingolimod in Austria: benefit-risk data from the Austrian Multiple Sclerosis Treatment Registry

Real life use of natalizumab and fingolimod in Austria: benefit-risk data from the Austrian Multiple Sclerosis Treatment Registry

Dr. Guger discusses the most current research on the use of natalizumab an…

Expiration Date: 2/5/2016

Max Credits: 0

View Activity

Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study

Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study

Dr. Cortese discusses research on the effect of vitamin D levels via cod l…

Expiration Date: 2/5/2016

Max Credits: 0

View Activity

Multiple Sclerosis and Women’s Health: Dispelling Myths and Improving Care

Multiple Sclerosis and Women’s Health: Dispelling Myths and Improving Care

Multiple sclerosis (MS), a chronic inflammatory disease of the central ner…

Expiration Date: 1/22/2016

Max Credits: 0

View Activity

Early brain volume loss on interferon predicts disability progression after 4 years

Early brain volume loss on interferon predicts disability progression after 4 years

Dr. Pérez-Miralles discusses the early implications of brain volume losses…

Expiration Date: 11/12/2016

Max Credits: 0

View Activity

Treatment strategies – determining treatment failure, what to do next

Treatment strategies – determining treatment failure, what to do next

Dr. Miller discusses defining treatment failure discussing subsequent trea…

Expiration Date: 11/12/2016

Max Credits: 0

View Activity

Optimizing Patient Safety and Outcomes by Individualizing Therapy

Optimizing Patient Safety and Outcomes by Individualizing Therapy

Since the approval of interferon beta-1b, multiple additional therapies ha…

Expiration Date: 11/12/2016

Max Credits: 0

View Activity

Making Informed Decisions When Screening and Monitoring

Making Informed Decisions When Screening and Monitoring

Since the approval of interferon beta-1b, multiple additional therapies ha…

Expiration Date: 11/12/2016

Max Credits: 0

View Activity